There was no significant difference in the onset of clinical score 1 between the two groups. n = 7 for G93A ALS mice + TAT; n = 14 for G93A ALS mice + P110; probability by one‐way ANOVA (with uncorrected Fisher's LSD post hoc test). An experimenter who was blind to genotypes and drug groups conducted all the behavior and survival studies. Mean, standard deviation, and P‐values are shown.